Journal
CELL CHEMICAL BIOLOGY
Volume 26, Issue 5, Pages 623-+Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2019.01.008
Keywords
-
Categories
Funding
- National Cancer Institute [R35CA209896, P01CA087497]
Ask authors/readers for more resources
Ferroptosis is a form of regulated cell death that can be induced by inhibition of the cystine-glutamate antiporter, system x(c)(-). Among the existing system x(c)(-) inhibitors, imidazole ketone erastin (IKE) is a potent, metabolically stable inhibitor of system xc and inducer of ferroptosis potentially suitable for in vivo applications. We investigated the pharmacokinetic and pharmacodynamic features of IKE in a diffuse large B cell lymphoma (DLBCL) xenograft model and demonstrated that IKE exerted an antitumor effect by inhibiting system x(c)(-), leading to glutathione depletion, lipid peroxidation, and the induction of ferroptosis biomarkers both in vitro and in vivo. Using untargeted lipidomics and qPCR, we identified distinct features of lipid metabolism in IKE-induced ferroptosis. In addition, biodegradable polyethylene glycol-poly(lactic-co-glycolic acid) nanoparticles were employed to aid in IKE delivery and exhibited reduced toxicity compared with free IKE in a DLBCL xenograft model.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available